Product NDC: | 62175-190 |
Proprietary Name: | GlycoLax |
Non Proprietary Name: | Polyethylene Glycol 3350 |
Active Ingredient(s): | 17 g/17g & nbsp; Polyethylene Glycol 3350 |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62175-190 |
Labeler Name: | Kremers Urban Pharmaceuticals Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | ANDA090600 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091006 |
Package NDC: | 62175-190-14 |
Package Description: | 238 g in 1 BOTTLE (62175-190-14) |
NDC Code | 62175-190-14 |
Proprietary Name | GlycoLax |
Package Description | 238 g in 1 BOTTLE (62175-190-14) |
Product NDC | 62175-190 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Polyethylene Glycol 3350 |
Dosage Form Name | POWDER, FOR SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20091006 |
Marketing Category Name | ANDA |
Labeler Name | Kremers Urban Pharmaceuticals Inc. |
Substance Name | POLYETHYLENE GLYCOL 3350 |
Strength Number | 17 |
Strength Unit | g/17g |
Pharmaceutical Classes |